Gendy Mellisa Mojica Barreneche
Research Subjects
Gendy Mellisa Mojica Barreneche has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Karla Leslie Martínez Hernández
Universidad Anáhuac México
2 shared publications - Andres Felipe Herrera Homez
Avances en Estrategias Basadas en Imágenes para la Detección Temprana del Melanoma Amelanótico Validación Clínica y Perspectivas Internacionales Hospital de Alta Especialidad Quality Consulting /ieccmexico.com/publishing un artículo de acceso abierto distribuido Bicentenario de la Independencia Pontificia Universidad Javeriana Cali EPS Sanitas Universidad Anáhuac México Pontificia Universidad Javeriana Instituto de Educación Capacitación y Certificación de México. https
1 shared publication - Carolina Paola Ortiz Valdés
Hospital de Alta Especialidad Bicentenario de la Independencia ISSSTE
1 shared publication - Dominique Magdalena Nathan Kreisberg
Universidad Andres Bello
1 shared publication - Hillary Yahiry Mejía Montiel
Servicios Médicos Integrales Populares S.A
1 shared publication - Jorge Angel Velasco Espinal
Universidad del Valle de Cuernavaca
1 shared publication
Latest Publications
- Open Access
- 28 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in International Science Journal
- Vol. 3 (1)
The Skin Microbiome as a Systemic Immunological Regulator: From Dysbiosis to Clinical Applications
The skin microbiome has emerged as a key regulator of immune function with significant implications for systemic disease. This review aims to analyze the role of cutaneous microbial communities in immune modulation and their contribution to the development, diagnosis, and treatment of systemic conditions. A structured narrative review was conducted using a scientific methodological framework, integrating evidence from dermatology, immunology, and microbiology. The findings indicate that microbial dysbiosis is consistently associated with immune imbalance, barrier dysfunction, and systemic inflammation. Key mechanisms include Toll-like receptor activation, cytokine modulation, and T-cell differentiation, which collectively influence disease progression. Additionally, the study highlights the growing relevance of the gut-skin axis as a pathway connecting local microbial changes with systemic outcomes. Diagnostic applications, particularly microbiome-based biomarkers, demonstrate potential for disease prediction and monitoring, while therapeutic strategies such as probiotics, bacteriotherapy, and antimicrobial peptides represent emerging approaches in personalized medicine. However, variability across populations and methodological heterogeneity remain significant challenges. This review underscores the importance of the skin microbiome as a central component in human health and supports its integration into future clinical and research frameworks, particularly in diverse international contexts..
- 28 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in International Science Journal
- Vol. 3 (1)
Open AccessThe Skin Microbiome as a Systemic Immunological Regulator: From Dysbiosis to Clinical Applications
The skin microbiome has emerged as a key regulator of immune function with significant implications for systemic disease. This review aims to analyze the role of cutaneous microbial communities in immune modulation and their contribution to the development, diagnosis, and treatment of systemic conditions. A structured narrative review was conducted using a scientific methodological framework, integrating evidence from dermatology, immunology, and microbiology. The findings indicate that microbial dysbiosis is consistently associated with immune imbalance, barrier dysfunction, and systemic inflammation. Key mechanisms include Toll-like receptor activation, cytokine modulation, and T-cell differentiation, which collectively influence disease progression. Additionally, the study highlights the growing relevance of the gut-skin axis as a pathway connecting local microbial changes with systemic outcomes. Diagnostic applications, particularly microbiome-based biomarkers, demonstrate potential for disease prediction and monitoring, while therapeutic strategies such as probiotics, bacteriotherapy, and antimicrobial peptides represent emerging approaches in personalized medicine. However, variability across populations and methodological heterogeneity remain significant challenges. This review underscores the importance of the skin microbiome as a central component in human health and supports its integration into future clinical and research frameworks, particularly in diverse international contexts..
- 20 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Advances in Image-Based Strategies for the Early Detection of Amelanotic Melanoma: Clinical Validation and International Perspectives
Amelanotic melanoma represents a diagnostically challenging subtype of melanoma due to the absence or minimal presence of pigmentation, which often leads to delayed recognition and poorer clinical outcomes. Early detection is therefore critical, yet traditional visual and dermoscopic criteria demonstrate limited sensitivity for non-pigmented lesions. In recent years, advanced image-based diagnostic approaches have shown promising performance in melanoma detection; however, their applicability to amelanotic melanoma and their validation across diverse clinical contexts remain insufficiently explored. This review analyzes current evidence on image-based strategies for the early detection of amelanotic melanoma, focusing on diagnostic performance, clinical validation, and integration into real-world practice. A structured narrative review methodology was employed, synthesizing findings from comparative performance studies, clinical validation trials, benchmarking initiatives, and meta-analyses. The results indicate that while image-based approaches can enhance diagnostic sensitivity and support clinician decision-making, their effectiveness is strongly influenced by dataset representation, lesion subtype complexity, and clinician–system interaction. Evidence further supports the value of multimodal diagnostic pathways that integrate clinical evaluation, dermoscopy, image-based analysis, and adjunctive imaging in diagnostically ambiguous cases.
- 20 December 2025
- Published by Quality Consulting Instituto de Educación Capacitación y Certificación de México in IECCMEXICO
- Vol. 3 (1)
Advances in Image-Based Strategies for the Early Detection of Amelanotic Melanoma: Clinical Validation and International Perspectives
Amelanotic melanoma represents a diagnostically challenging subtype of melanoma due to the absence or minimal presence of pigmentation, which often leads to delayed recognition and poorer clinical outcomes. Early detection is therefore critical, yet traditional visual and dermoscopic criteria demonstrate limited sensitivity for non-pigmented lesions. In recent years, advanced image-based diagnostic approaches have shown promising performance in melanoma detection; however, their applicability to amelanotic melanoma and their validation across diverse clinical contexts remain insufficiently explored. This review analyzes current evidence on image-based strategies for the early detection of amelanotic melanoma, focusing on diagnostic performance, clinical validation, and integration into real-world practice. A structured narrative review methodology was employed, synthesizing findings from comparative performance studies, clinical validation trials, benchmarking initiatives, and meta-analyses. The results indicate that while image-based approaches can enhance diagnostic sensitivity and support clinician decision-making, their effectiveness is strongly influenced by dataset representation, lesion subtype complexity, and clinician–system interaction. Evidence further supports the value of multimodal diagnostic pathways that integrate clinical evaluation, dermoscopy, image-based analysis, and adjunctive imaging in diagnostically ambiguous cases.